Assertio Therapeutics, 5% 15aug2024, USD (Conv.) (FIGI BBG00PYZN0L0)
国内債券, 転換社債, トレース適格, Senior Unsecured
国内債券, 転換社債, トレース適格, Senior Unsecured
|
As a result of the Assertio Reorganization, Assertio Holdings became the successor issuer to Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc., formerly Depomed Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for ...
As a result of the Assertio Reorganization, Assertio Holdings became the successor issuer to Assertio Therapeutics, Inc.
Assertio Therapeutics, Inc., formerly Depomed Inc., a specialty pharmaceutical company, engages in the development, sale, and licensing of products for pain and other central nervous system conditions in the United States.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
80 234
株
167 970
ETF&投資信託
70 000
インデックス
最も効率的な方法でポートフォリオを追跡